From Drug Delivery to Tissue Engineering: Bioengineering and its Impact on Human Health

In honor of Robert Langer, Sc.D., and Alian Carpentier, M.D., Ph.D. for their extraordinary contributions to medicine and innovations in bioengineering.

Opening Remarks

Jeffrey S. Flier, MD

Dean of the Faculty of Medicine, Harvard University

Presentations

Alain F. Carpentier, MD, PhD

Chief of Cardiovascular Surgery, Hôptial Européen Georges-Pompidou

Bioengineering and Its Impact on Cardiac Surgery

Robert S. Langer Jr., ScD

David H. Koch Institute Professor, Massachusetts Institute of Technology

Biomaterials and Biotechnology: From the Development of Controlled Drug Delivery Systems to the Foundation of Tissue Engineering

David J. Mooney, PhD

School of Applied Engineering and Wyss Institute for Biologically Inspired Engineering, Harvard University

Infection-Mimicking Polymers as a Cancer Vaccine

Sangeeta Bhatia, MD, PhD

Health Sciences and Technology and Electrical Engineering and Computer Science, Massachusetts Institute of Technology

Cancer Nanotechnology to Hepatic Tissue Engineering

William Shih, PhD

Dana-Farber Cancer Institute, Harvard Medical School, and Wyss Institute for Biologically Inspired Engineering, Harvard University

DNA Nanostructures as Building Blocks for Future Therapeutics

Sign up to receive updates

Sign up to receive updates

Past Symposia

For questions about the prize, please contact us.

Contact Us
Shortly after the discovery of the CFTR gene, I wrote a song called “Dare to Dream.” The lyrics expressed the hope that someday the gene discovery would lead to effective treatments for cystic fibrosis—that someday we would see “all our brothers and sisters breathing free.” It is intensely gratifying to see that dream now coming true. And it is a profound honor to have the chance to share in this Warren Alpert recognition with other heroes who have made it possible. That includes my friend Lap-Chee Tsui, whose team worked with Mitch Drumm, Mike Iannuzzi, and others in my group in an unprecedented international collaboration that effectively merged our labs. And it includes Drs. Welsh, Ramsey and Negulescu, who are truly inspiring leaders in the work that led to the current therapeutic advances. They all dared to dream.
- Francis Collins

Francis Collins | 2018 Recipient

Francis S. Collins, M.D., Ph.D. was appointed the 16th Director of the National Institutes of Health (NIH) by President Barack Obama and confirmed by the Senate. He was sworn in on August 17, 2009. On June 6, 2017, President Donald Trump announced his selection of Dr. Collins to continue to serve as the NIH Director. In this role, Dr. Collins oversees the work of the largest supporter of biomedical research in the world, spanning the spectrum from basic to clinical research.

Dr. Collins is a physician-geneticist noted for his landmark discoveries of disease genes and his leadership of the international Human Genome Project, which culminated in April 2003 with the completion of a finished sequence of the human DNA instruction book. He served as director of the National Human Genome Research Institute at NIH from 1993-2008.

Before coming to NIH, Dr. Collins was a Howard Hughes Medical Institute investigator at the University of Michigan. He is an elected member of the National Academy of Medicine and the National Academy of Sciences, was awarded the Presidential Medal of Freedom in November 2007, and received the National Medal of Science in 2009.

 View Past Recipients